Literature DB >> 226830

Apolipoprotein C-II and C-III levels in hyperlipoproteinemia.

G Schonfeld, P K George, J Miller, P Reilly, J Witztum.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 226830     DOI: 10.1016/0026-0495(79)90004-0

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  33 in total

1.  Complexities of plasma apolipoprotein C-III metabolism.

Authors:  Frank M Sacks; Chunyu Zheng; Jeffrey S Cohn
Journal:  J Lipid Res       Date:  2011-03-18       Impact factor: 5.922

2.  ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors.

Authors:  Philip L S M Gordts; Ryan Nock; Ni-Huiping Son; Bastian Ramms; Irene Lew; Jon C Gonzales; Bryan E Thacker; Debapriya Basu; Richard G Lee; Adam E Mullick; Mark J Graham; Ira J Goldberg; Rosanne M Crooke; Joseph L Witztum; Jeffrey D Esko
Journal:  J Clin Invest       Date:  2016-07-11       Impact factor: 14.808

3.  Purification, cloning and nucleotide sequence determination of cynomolgus monkey apolipoprotein C-II: comparison to the human sequence.

Authors:  B E Whitted; C K Castle; H G Polites; G W Melchior; K R Marotti
Journal:  Mol Cell Biochem       Date:  1989-10-05       Impact factor: 3.396

4.  Multidimensional regulation of lipoprotein lipase: impact on biochemical and cardiovascular phenotypes.

Authors:  Robert A Hegele
Journal:  J Lipid Res       Date:  2016-07-13       Impact factor: 5.922

5.  Increased high density lipoproteins in diabetic children.

Authors:  U Ewald; S Gustafson; T Tuvemo; B Vessby
Journal:  Eur J Pediatr       Date:  1984-08       Impact factor: 3.183

6.  Apo CIII gene transcription is regulated by a cytokine inducible NF-kappa B element.

Authors:  P J Gruber; A Torres-Rosado; M L Wolak; T Leff
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

7.  An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population.

Authors:  Q Zeng; M Dammerman; Y Takada; A Matsunaga; J L Breslow; J Sasaki
Journal:  Hum Genet       Date:  1995-04       Impact factor: 4.132

8.  Effects of dietary cholesterol and fatty acids on plasma lipoproteins.

Authors:  G Schonfeld; W Patsch; L L Rudel; C Nelson; M Epstein; R E Olson
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

9.  Radioimmunoassay of human arginine-rich apolipoprotein, apoprotein E. Concentration in blood plasma and lipoproteins as affected by apoprotein E-3 deficiency.

Authors:  R J Havel; L Kotite; J L Vigne; J P Kane; P Tun; N Phillips; G C Chen
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

10.  Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions.

Authors:  Meenakshi Sundaram; Shumei Zhong; Maroun Bou Khalil; Philip H Links; Yang Zhao; Jahangir Iqbal; M Mahmood Hussain; Robin J Parks; Yuwei Wang; Zemin Yao
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.